Kymera Therapeutics Inc. (KYMR)

KYMR trades at $42.62, 6.5% above the near-term max pain of $40 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($20-$45), signaling increased put positioning or downside protection. Key magnetic zone at 40 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for KYMR shows a downward trend from 45 to 20, indicating bearish sentiment or hedging activity. The 71% spread signals divergent expectations across timeframes. Most levels below 42.62 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.